Episode
Quantum Computing Is Becoming a Clinical Trial Accelerator
- Published
- Jun 13, 2026
- Duration seconds
- 639
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/quantum-computing-business-with-fexingo-hardware-software-and-enterprise-quantum-7872009/episodes/quantum-computing-is-becoming-a-clinical-trial-accelerator/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/quantum-computing-business-with-fexingo-hardware-software-and-enterprise-quantum-7872009/quantum-computing-is-becoming-a-clinical-trial-accelerator.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Episode 49 of Quantum Computing Business with Fexingo dives into how quantum computers are starting to reshape clinical trial design. Lucas and Luna explore a concrete example: a mid-stage biotech using a quantum algorithm to optimize patient stratification for a Phase 2 cancer trial. They walk through the problem—finding the right patient subgroups to reduce trial size and duration—and how a hybrid quantum-classical approach cut the search space from 10^15 possibilities to a manageable 200 in under 4 hours. The hosts also discuss what this means for drug developers, regulators, and patients, including the role of quantum in adaptive trial designs and the current limitations of noisy intermediate-scale quantum hardware. A grounded look at a real use case that moves quantum from theory to a very practical, high-stakes application. #QuantumComputing #ClinicalTrials #Biotech #DrugDevelopment #PatientStratification #QuantumAlgorithms #HybridQuantumClassical #Phase2Trials #AdaptiveTrials #CRO #PrecisionMedicine #NISQ #FexingoBusiness #BusinessPodcast #BusinessAndTechnology #HealthcareInnovation #RDAccelerator #QuantumBusiness Keep every episode free: buymeacoffee.com/fexingo